Stockreport

ArriVent BioPharma: Bringing A Novel Cancer Drug From China [Seeking Alpha]

ArriVent BioPharma, Inc.  (AVBP) 
PDF Investing Group Leader Follow Play 10min Summary ArriVent BioPharma's lead molecule, firmonertinib, targets NSCLC with EGFR Exon 20 insertion mutations and sh [Read more]